{"id":5451,"date":"2014-02-27T16:31:29","date_gmt":"2014-02-27T15:31:29","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=5451"},"modified":"2014-02-27T16:31:29","modified_gmt":"2014-02-27T15:31:29","slug":"linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","title":{"rendered":"L\u00edneas estrat\u00e9gicas del Plan de salud: implicaciones para la farmacia comunitaria"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/cofb.140213-32.jpg\"><img decoding=\"async\" class=\"alignleft  wp-image-5453\" alt=\"cofb.140213-32\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/cofb.140213-32.jpg\" width=\"269\" height=\"179\" \/><\/a>El Plan de Salud 2011-2015 es un documento estrat\u00e9gico que articula la reforma del sistema sanitario y comporta la implicaci\u00f3n del farmac\u00e9utico en parte de sus l\u00edneas estrat\u00e9gicas, al tiempo que marca la necesidad de afrontar el reto estructural de la cronicidad, con una estrategia de cambio integral en el modelo asistencial. De estas premisas parte el curso que acoge el Colegio llamado &quot;Las l\u00edneas estrat\u00e9gicas del Plan de Salud: implicaciones para la farmacia comunitaria&quot;. Coordinado por Merc\u00e8 Barau, vocal de la Junta de Gobierno del COFB, <strong>las sesiones persiguen el objetivo de revisar los principales grupos estrat\u00e9gicos para formar a los farmac\u00e9uticos en las funciones asistenciales que pueden realizar desde la oficina de farmacia.<\/strong><\/p>\n<p><span style=\"color: #808080;\" data-mce-mark=\"1\"><b>El documento se fundamenta en tres ejes: dar respuesta a las nuevas necesidades sociales, establecer los objetivos de salud a alcanzar y concretar las acciones prioritarias a realizar para afrontar las necesidades detectadas, como los h\u00e1bitos de vida poco saludables que conllevan el aparici\u00f3n de enfermedades como la diabetes, el c\u00e1ncer, la EPOC y la insuficiencia card\u00edaca y respiratoria. <\/b><\/span><\/p>\n<p>Cada tema se imparte en dos sesiones (una te\u00f3rica y otra de taller), excepto la \u00faltima que es una sesi\u00f3n \u00fanica. El tema escogido por la primera clase, que tuvo lugar el 13 de febrero, fue el tratamiento de la enfermedad pulmonar obstructiva cr\u00f3nica (EPOC) y el pr\u00f3ximo 13 de marzo los alumnos asistir\u00e1n a un taller de manejo de inhaladores. Los otros temas que se abordar\u00e1n ser\u00e1n la diabetes (8 de mayo), un taller de insulinizaci\u00f3n (12 de junio), la insuficiencia card\u00edaca en la atenci\u00f3n primaria (19 de junio), taller de AMPA\/MAPA (3 de julio) y una sesi\u00f3n final sobre cronicidad en Catalu\u00f1a (18 de septiembre).<\/p>\n<p>El curso, patrocinado por <span style=\"text-decoration: underline;\">Esteve<\/span>, <strong>est\u00e1 dirigido a farmac\u00e9uticos de oficina de farmacia familiarizados con los conceptos de atenci\u00f3n farmac\u00e9utica o bien que forman parte de alg\u00fan programa de atenci\u00f3n farmac\u00e9utica<\/strong>, como el FarmaEPOC o el test r\u00e1pido de detecci\u00f3n de VIH.<\/p>\n<p>El profesorado que participa en estas sesiones es el siguiente:<\/p>\n<ul>\n<li>Mariano De la Figuera, grupo de trabajo de hipertensi\u00f3n arterial de la CAMFiC<\/li>\n<li>\u00a0Xavier Flor, grupo de trabajo de enfermedades respiratorias de la CAMFiC<\/li>\n<li>Sonia Fuentes, grupo de trabajo de enfermedades del coraz\u00f3n de la CAMFiC<\/li>\n<li>Manel Mata, grupo de trabajo de GEDAPS (Grupo de Estudio sobre Diabetes en la APS)<\/li>\n<li>Sonia P\u00e9rez, m\u00e9dico de la Direcci\u00f3n de Atenci\u00f3n Primaria del CIS, Cotxeres<\/li>\n<\/ul>\n<h6 style=\"text-align: right;\"><span style=\"color: #808080;\"><strong>Con el patrocinio de:<\/strong><\/span><\/h6>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/esteve.jpg\"><img decoding=\"async\" class=\"wp-image-5489 alignright\" alt=\"esteve\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/esteve.jpg\" width=\"137\" height=\"53\" \/><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>El Plan de Salud 2011-2015 es un documento estrat\u00e9gico que articula la reforma del sistema sanitario y comporta la implicaci\u00f3n del farmac\u00e9utico en parte de sus l\u00edneas estrat\u00e9gicas, al tiempo que marca la necesidad de afrontar el reto estructural de la cronicidad, con una estrategia de cambio integral en el modelo [\u2026]<\/p>","protected":false},"author":1,"featured_media":5453,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70,76],"class_list":["post-5451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio","tag-oficina-de-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-27T15:31:29+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria\",\"datePublished\":\"2014-02-27T15:31:29+00:00\",\"dateModified\":\"2014-02-27T15:31:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"},\"wordCount\":453,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\",\"Oficina de farm\u00e0cia\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\",\"name\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-02-27T15:31:29+00:00\",\"dateModified\":\"2014-02-27T15:31:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","og_locale":"es_ES","og_type":"article","og_title":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-02-27T15:31:29+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria","datePublished":"2014-02-27T15:31:29+00:00","dateModified":"2014-02-27T15:31:29+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"},"wordCount":453,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3","Oficina de farm\u00e0cia"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","url":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","name":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-02-27T15:31:29+00:00","dateModified":"2014-02-27T15:31:29+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/5451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=5451"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/5451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=5451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=5451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=5451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}